Actively Recruiting
99mTc-H7ND SPECT/CT Imaging in NSCLC
Led by First Affiliated Hospital Xi'an Jiaotong University · Updated on 2023-09-25
150
Participants Needed
1
Research Sites
151 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To study the clinical application of 99mTc-H7ND SPECT/CT imaging in the efficacy evaluation and prediction of non-small cell lung cancer (NSCLC)
CONDITIONS
Official Title
99mTc-H7ND SPECT/CT Imaging in NSCLC
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged from 18 to 80 years old
- NSCLC confirmed by needle aspiration cytology or surgical pathology
- Unable to undergo radical surgery due to recurrence, metastasis, or personal conditions
- Completed 2-4 cycles of first-line therapy and assessed as stable disease by RECIST 1.1
- At least one measurable lesion
- No local radiotherapy for primary or metastatic lesions within 28 days
- ECOG performance status score between 0 and 2
- Expected survival time of 3 months or more
- Voluntary participation with signed informed consent
You will not qualify if you...
- Women who are pregnant, lactating, or planning pregnancy within 6 months
- Severe brain or bone metastases
- Severe anemia or severe liver and kidney damage
- Lack of pathological or long-term follow-up results
- Missing relevant control imaging or clinical data
- Severe illnesses that hinder cooperation, such as acute cardiovascular or cerebrovascular events
- Surgery or invasive treatment within 4 weeks before enrollment
- Unable to tolerate standard second-line or other first-line therapies
- Known allergy to 99mTc-H7ND or its components or history of severe allergies
- Presence of imaging contraindications
- Investigator's judgment deeming participation inappropriate
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China, 710061
Actively Recruiting
Research Team
R
Rui Gao
CONTACT
X
Xinru Li
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here